6 results
Antiplatelet Conversion - Switching Between P2Y12 Inhibitors
Oral P2Y12 inhibitors vary in potency and pharmacokinetic and dynamic
Antiplatelet Conversion ... inhibitors during ... Drug interactions ... Inhibitor #switching #conversion ... ticagrelor #prasugrel #pharmacology
Angiotensin Receptor Blockers 
Recommended Dose Conversions 

Valsartan 
Irbesartan 
Losartan 
Olmesartan 
Telmisartan 
Candesartan 
Azilsartan 
Eprosartan 

A few
dose of another drug ... in that class. ... recalls, this drug ... #Table #Dosing ... #Pharmacology #Dose
Anti-infective stewardship, including tips for using anti-infectives wisely, criteria for stepdown from IV to PO dosage
including tips for using ... dosage forms and conversion ... #pharmacology #antibiotics ... #medications #table ... #treatment #drugs
Antiplatelet Conversion - Switching Between Oral P2Y12 Inhibitors
A, Switching between oral agents in the acute/early phase.
Antiplatelet Conversion ... dose of a given drug ... the timing and dosing ... dose of a given drug ... ticagrelor #prasugrel #pharmacology
Clinically Significant Cardiovascular Drug-Drug Interactions With OTC Supplements and Herbal Products
Angiotensin-Converting Enzyme Inhibitors (ACEIs)
 • Night-blooming
Cardiovascular Drug-Drug ... potential arrhythmias Class ... Antiarrhythmic Drugs ... supplementals #herbal #pharmacology ... #DDI #table #cardiology
Daliresp (Roflumilast) 
Indication: Reduce risk of COPD exacerbations 
Drug Class: Selective Phosphodiesterase-4 (PDE4) Inhibitor 
GOLD 2019
exacerbations Drug ... Class: Selective ... Eosinophils < 100 Dosing ... : 250 mcg tablet ... #Indications #Pharmacology